Immune recovery markers in a double blind clinical trial comparing dolutegravir and raltegravir based regimens as initial therapy (SPRING-2)

  1. Blanco, J.-R.
  2. Alejos, B.
  3. Moreno, S.
Revue:
PLoS ONE

ISSN: 1932-6203

Année de publication: 2020

Volumen: 15

Número: 1

Type: Article

DOI: 10.1371/JOURNAL.PONE.0226724 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus